Cargando…
HoxA9 binds and represses the Cebpa +8 kb enhancer
C/EBPα plays a key role in specifying myeloid lineage development. HoxA9 is expressed in myeloid progenitors, with its level diminishing during myeloid maturation, and HOXA9 is over-expressed in a majority of acute myeloid leukemia cases, including those expressing NUP98-HOXD13. The objective of thi...
Autores principales: | Peng, Lei, Guo, Hong, Ma, Peilin, Sun, Yuqing, Dennison, Lauren, Aplan, Peter D., Hess, Jay L., Friedman, Alan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532930/ https://www.ncbi.nlm.nih.gov/pubmed/31120998 http://dx.doi.org/10.1371/journal.pone.0217604 |
Ejemplares similares
-
PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression
por: Cai, Sidong, et al.
Publicado: (2020) -
The cohesin subunit Rad21 is a negative regulator of hematopoietic self-renewal through epigenetic repression of HoxA7 and HoxA9
por: Fisher, Joseph B., et al.
Publicado: (2016) -
In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis
por: Guo, Hong, et al.
Publicado: (2016) -
HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia
por: Brumatti, Gabriela, et al.
Publicado: (2013) -
The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors
por: Cooper, Stacy, et al.
Publicado: (2015)